Y-Intercept (HK)’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Y-Intercept (HK)’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,540	Closed	-$1.12M	–	1849
2023 Q4	$1.12M	Buy	+3,540	New	+$688K	0.1%	277
2022 Q4	–	Sell	-2,312	Closed	-$520K	–	1437
2022 Q3	$520K	Buy	+2,312	New	+$468K	0.05%	523

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Y-Intercept (HK)'s KRTX Position: Q1 2024 in Review

Y-Intercept (HK) sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 3,540 shares — an estimated $1.12M sold.

Y-Intercept (HK) first reported a position in KRTX in Q3 2022 and held it in 2 quarters. The position peaked at $1.12M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Y-Intercept (HK) reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Y-Intercept (HK) sold 3,540 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.12M.
Y-Intercept (HK) first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
Y-Intercept (HK)'s Karuna Therapeutics, Inc. Common Stock position peaked at $1.12M in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Y-Intercept (HK)'s 13F filing for Q1 2024, filed 10 May 2024.